Approval of Ubrelvy follows several new migraine drugs.
The fish oil drug is approved to reduce cardiovascular risk.
This is the agency’s first generic approvals of Gilenya.
Sandoz now has 2 biosimilars to the popular cancer drug.
This is the eighth indication approved for Xarelto.
Drug is the only respiratory therapy that can be given at home every 8 weeks.
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
Targeted therapy gives new hope to patients with an aggressive form of lung cancer.
The new drug is an add-on to levodopa/carbidopa for Parkinson’s patients experiencing “off” episodes.
Blockbuster drug could be key to Humira’s successor.